arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Xenetic Biosciences, Inc.

XBIO

$2.91 ▲ +0.08 (+2.83%) at close

15 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Xenetic Biosciences, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.0M

Dividend Yield —

Revenue Growth 19.0% ↗

Op. Margin -95.2% ↗

ROIC -30.3% ↗

FCF / Share $-1.34 ↗

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 5, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.98M

↑ +19.0% —

Net Income Profit after all expenses

$-2.68M

↑ +32.3% —

Operating Margin Operating profit as % of sales

-95.2%

↑ +43.4% 2th

FCF / Share Free cash flow per share

$-1.34

↑ +26.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Revenue Growth YoY (%)	19.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+138%)	-1.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-120%)	48.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+510%)	47.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+488%)	165.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1970%)	2460.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+30654%)	—	N/M	152.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1810%)	—	—	N/M	240.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2907%)	—	—
EPS Growth YoY (%)	38.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	5.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-489.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	16.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	32.3% Excellent ↑ Excellent Improving Year-over-year change in net income	4.2% Caution ↓ Caution Declining Year-over-year change in net income	36.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-16.1% Weak ↓ Weak Declining Year-over-year change in net income	48.2% Excellent ↑ Excellent Improving Year-over-year change in net income	14.7% Fair ↑ Fair Improving Year-over-year change in net income	-75.0% Weak ↑ Weak Improving Year-over-year change in net income	-103.1% Weak ↓ Weak Declining Year-over-year change in net income	93.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-333.4% Weak ↓ Weak Declining Year-over-year change in net income	12.6% Fair ↑ Fair Improving Year-over-year change in net income	-66.8% Weak Weak Year-over-year change in net income	-35.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	26.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	32.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-724.1% Weak Weak Year-over-year change in free cash flow	29.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	20.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	29.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	79.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	364.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	-61.4% Weak Weak Compound annual revenue growth over 3 years	-82.1% Weak Weak Compound annual revenue growth over 3 years	—	—	44.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	46.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	171.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	—	-25.8% Weak Weak Compound annual revenue growth over 5 years	-17.3% Weak Weak Compound annual revenue growth over 5 years	—	—	—	91.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Operating Margin (%) (%)	-95.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-735%)	-168.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1221%)	-177.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1285%)	-393.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2724%)	-495.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3401%)	—	—	—	-47.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-414%)	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	-90.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-851%)	-158.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1420%)	-162.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1456%)	-383.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3299%)	-486.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4153%)	—	—	—	-47.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-495%)	—	—	—	—	—	—
FCF Margin (%) (%)	-76.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-112.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-162.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-272.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-408.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	19.6% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	-293.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Return on Invested Capital (%)	-30.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-90.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-231.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-117.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-123.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-226.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-79.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-25.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-36.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-342%)	-65.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-540%)	-42.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-48.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-420%)	-30.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-305%)	-89.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-695%)	-74.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-595%)	-73.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-591%)	-25.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	—	-189.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1362%)	-136.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1010%)	-68.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-553%)	-30.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-303%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	120.57x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+19996%)
Interest Coverage (x)	—	—	—	—	—	—	-1610853.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12147.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1963.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-65.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2746.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13524.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-122.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$212.81K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Revenue per Share (USD)	$1.75	$1.62	$1.66	$0.12	$0.11	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.58	$-2.57	$-2.71	$-0.46	$-0.55	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.34	$-1.83	$-2.69	$-0.33	$-0.46	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.23	$3.90	$6.36	$0.90	$1.37	$1.40	$2.84	$12.65	$20.41	$42.31	$17.29	$0.90	$1.26	$2.08	—
Tangible Book Value per Share (USD)	$3.23	$3.90	$6.36	$0.90	$1.37	$1.40	$2.84	$8.46	$15.73	$33.72	$8.70	$0.60	$0.90	$1.72	—
Basic Weighted Avg Shares (shares)	1.70M	1.54M	1.53M	14.22M	10.28M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Working Capital (USD)	$7.08M	$5.69M	$8.78M	$12.58M	$17.30M	$11.43M	$9.67M	$-405.82K	$3.94M	$6.47M	$-3.15M	$78.49K	$1.74M	$10.15M	$2.08K
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$212.81K
Total Equity (USD)	$7.40M	$6.01M	$9.80M	$13.65M	$18.39M	$12.22M	$17.21M	$9.91M	$14.30M	$16.17M	$6.61M	$10.48M	$12.62M	$20.78M	$1.76K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$2.98M	$2.50M	$2.54M	$1.71M	$1.16M	$436.94K	$17.07K	$0.00	$7.58M	$3.00M	$0.00	$0.00	$1.00M	$293.60K	—
Depreciation Expense (USD)	—	—	—	—	—	$757.00	$4.20K	$15.83K	$23.78K	$36.45K	$56.12K	$83.86K	$52.03K	$104.62K	—
Net Income, GAAP (USD)	$-2.68M	$-3.96M	$-4.13M	$-6.55M	$-5.65M	$-10.89M	$-12.78M	$-7.30M	$-3.60M	$-54.21M	$-12.51M	$-14.31M	$-8.58M	$-6.33M	—
Operating Cash Flow (USD)	$-2.29M	$-2.82M	$-4.11M	$-4.65M	$-4.74M	$-4.27M	$-6.40M	$-6.46M	$1.49M	$-8.79M	—	—	—	$-6.26M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 61 quarters

Xenetic Biosciences, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare XBIO with peers